Skip to main content

News

Press release year list 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
12/30/2019
Masimo Announces FDA Clearance For Neonatal RD SET® Pulse Oximetry Sensors With Improved Accuracy Specifications
12/19/2019
Masimo And Dräger Expand Licensing Agreement To Add Masimo Brain Monitoring And Capnography Technologies
12/09/2019
Multicenter Study Evaluates Trend Accuracy of Noninvasive, Continuous Masimo SpHb® and Two Invasive Hemoglobin Testing Methods
12/02/2019
Masimo to Present at Evercore ISI 2nd Annual HealthCONx Conference
11/27/2019
Masimo to Present at Piper Jaffray 31st Annual Healthcare Conference
11/21/2019
Study Uses Masimo Patient SafetyNet™ and rainbow Acoustic Monitoring® to Investigate the Incidence of Desaturation and Bradypnea in Postoperative Patients
11/13/2019
Masimo to Present at Stifel 2019 Healthcare Conference
10/31/2019
Masimo Announces CE Marking of Radius Capnography™ for the Root® Patient Monitoring and Connectivity Platform
10/30/2019
Masimo Reports Third Quarter 2019 Financial Results
10/23/2019
Study Investigates Effects of Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, on Postoperative Anemia and Inappropriate Blood Transfusion in Patients Undergoing Hip and Knee Surgery
10/16/2019
Masimo to Report Third Quarter 2019 Financial Results after Market Close on Wednesday, October 30
09/23/2019
Study Investigates the Ability of Masimo Noninvasive, Continuous Hemoglobin (SpHb®) to Provide Earlier Indication of Anemia and the Impact of Anemia on Patient Outcomes
09/09/2019
Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3®
09/04/2019
Masimo to Present at Morgan Stanley 17th Annual Global Healthcare Conference
09/04/2019
Masimo Announces Pathway™, a Newborn Oxygenation Visualization Mode for the Root® Patient Monitoring and Connectivity Platform
08/26/2019
Study Investigates the Utility of Masimo ORi™, Oxygen Reserve Index, to Reduce Hyperoxia in Critically Ill Patients
08/15/2019
Masimo Announces Investment in Pulmonary Care Company TNI medical AG
08/07/2019
Study Demonstrates Reduction in Mortality Using Masimo Noninvasive, Continuous Hemoglobin (SpHb®) and Pleth Variability Index (PVi®) Monitoring
08/05/2019
Masimo Announces CE Marking of Neonatal Indication for Noninvasive, Continuous Hemoglobin Monitoring (SpHb®)
07/31/2019
Masimo Reports Second Quarter 2019 Financial Results
07/22/2019
Study Investigates the Ability of Continuous Noninvasive Hemoglobin Monitoring with Masimo SpHb® to Reflect Acute Hemodilution During Incremental Fluid Administration
07/17/2019
Masimo to Report Second Quarter 2019 Financial Results after Market Close on Wednesday, July 31
07/15/2019
New Study Investigates the Utility of Masimo ORi™, Oxygen Reserve Index, As an Indicator to Avoid Hyperoxia During General Anesthesia
07/12/2019
Company Profile for Masimo
06/24/2019
New Study Uses Masimo SedLine® Brain Function Monitoring to Assess the Prevalence of Isoelectric EEG Events in Infants and Young Children Undergoing General Anesthesia
06/10/2019
Masimo Announces FDA Clearance of Neonatal Indication for O3® Regional Oximetry
05/28/2019
NuVision Management Healthcare Consulting Company, One of the Largest U.S. Providers of Long-term Care for Medically Complex Children, Converts to Masimo
05/20/2019
New Study Evaluates Ability of Masimo SpHb® (Noninvasive Hemoglobin) to Estimate Timing for Invasive Measurement to Detect Anemia During Surgery
05/16/2019
Masimo Hosts 2019 Investor Day
05/16/2019
Masimo Announces FDA Clearance of Radius PPG™, the First Tetherless SET® Pulse Oximetry Sensor Solution
05/14/2019
Masimo to Present at UBS Global Healthcare Conference
05/13/2019
Masimo and Mindray Announce Expanded Partnership
05/06/2019
Masimo Reports First Quarter 2019 Financial Results
04/30/2019
Masimo Announces Halo ION™
04/29/2019
Masimo Announces First CE-marked Third-party Masimo Open Connect® Module for the Root® Patient Monitoring and Connectivity Hub
04/22/2019
Masimo to Report First Quarter 2019 Financial Results after Market Close on Monday, May 6
04/15/2019
New Study Investigates Cerebral Oxygenation Normative Values Using Masimo O3® Regional Oximetry
04/02/2019
Masimo to Present at 18th Annual Needham Healthcare Conference
03/25/2019
Masimo Announces FDA Clearance of the Rad-67™ Pulse CO-Oximeter® with Next Generation SpHb® Spot-check Monitoring & rainbow® DCI®-mini Reusable Sensor
03/19/2019
St. Luke’s University Health Network Achieves Compelling Outcome Results Following Implementation of Masimo Supplemental Remote Monitoring Solution
03/06/2019
Masimo to Present at Barclays Global Healthcare Conference
03/04/2019
Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine® Brain Function Monitoring
02/27/2019
Masimo to Present at Raymond James 40th Annual Institutional Investors Conference
02/26/2019
Masimo Reports Fourth Quarter and Full Year 2018 Financial Results
02/25/2019
New Case Series Investigates the Combined Use of Masimo SedLine® Brain Function Monitoring and O3® Regional Oximetry During Cardiac Surgery
02/18/2019
Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology
02/11/2019
Masimo Announces Doctella™, a Secure Cloud-based Patient Engagement and Remote Care Automation Platform
01/28/2019
Masimo Announces FDA Clearance of RRp®, Respiration Rate from the Pleth, on the MightySat™ Rx Spot-Check Fingertip Pulse Oximeter
01/22/2019
Masimo Announces U.S. Launch of Iris® Device Management System
01/09/2019
Masimo Announces Select Preliminary Full Year 2018 Financial Results and 2019 Outlook
01/07/2019
Julie A. Shimer Ph.D. Joins Masimo’s Board of Directors
01/02/2019
Masimo to Present at 37th Annual J.P. Morgan Healthcare Conference